# ALTUVIIIO

NDC: 71104-979
Generic name: Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl
Labeler / Manufacturer: Bioverativ Therapeutics Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20230222

FDA application: BLA125771

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71104-979"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71104-979
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01411972-df40-4ccf-88f0-d3220e5abda9